Markets Moderna Rockets 93% and Merck Jumps 7% as Melanoma Therapy Meets Phase 3 Goal August 19, 2026 Moderna and Merck Deliver Historic Breakthrough in Cancer Treatment Shares of Moderna rocketed 93% to $121.76 in early Wednesday trading after the biotech company and partner Merck announced that their…